Combining Short- and Long-Read Sequencing Technologies to Identify SARS-CoV-2 Variants in Wastewater.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
21 Sep 2024
Historique:
received: 10 08 2024
revised: 14 09 2024
accepted: 18 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

During the COVID-19 pandemic, the monitoring of SARS-CoV-2 RNA in wastewater was used to track the evolution and emergence of variant lineages and gauge infection levels in the community, informing appropriate public health responses without relying solely on clinical testing. As more sublineages were discovered, it increased the difficulty in identifying distinct variants in a mixed population sample, particularly those without a known lineage. Here, we compare the sequencing technology from Illumina and from Oxford Nanopore Technologies, in order to determine their efficacy at detecting variants of differing abundance, using 248 wastewater samples from various Quebec and Ontario cities. Our study used two analytical approaches to identify the main variants in the samples: the presence of signature and marker mutations and the co-occurrence of signature mutations within the same amplicon. We observed that each sequencing method detected certain variants at different frequencies as each method preferentially detects mutations of distinct variants. Illumina sequencing detected more mutations with a predominant lineage that is in low abundance across the population or unknown for that time period, while Nanopore sequencing had a higher detection rate of mutations that are predominantly found in the high abundance B.1.1.7 (Alpha) lineage as well as a higher sequencing rate of co-occurring mutations in the same amplicon. We present a workflow that integrates short-read and long-read sequencing to improve the detection of SARS-CoV-2 variant lineages in mixed population samples, such as wastewater.

Identifiants

pubmed: 39339971
pii: v16091495
doi: 10.3390/v16091495
pii:
doi:

Substances chimiques

Wastewater 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : FRN#175622
Pays : Canada
Organisme : Canada Foundation for Innovation
ID : CFI 33406
Organisme : Canada Foundation for Innovation
ID : CFI-MSI 35444
Organisme : Canada Foundation for Innovation
ID : #41012

Auteurs

Gabrielle Jayme (G)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Ju-Ling Liu (JL)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Jose Hector Galvez (JH)

Canadian Centre for Computational Genomics, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.

Sarah Julia Reiling (SJ)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Sukriye Celikkol (S)

Department of Civil Engineering, McGill University, Montreal, QC H3A 0C3, Canada.

Arnaud N'Guessan (A)

Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Research Centre, Montreal Heart Institute, Montreal, QC H1T 1C8, Canada.

Sally Lee (S)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Shu-Huang Chen (SH)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Alexandra Tsitouras (A)

Department of Civil Engineering, McGill University, Montreal, QC H3A 0C3, Canada.

Fernando Sanchez-Quete (F)

Department of Civil Engineering, McGill University, Montreal, QC H3A 0C3, Canada.

Thomas Maere (T)

modelEAU, Département de génie civil et de génie des eaux, Université Laval, Québec City, QC G1V 0A6, Canada.

Eyerusalem Goitom (E)

Department of Geography & Environmental Studies, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada.

Mounia Hachad (M)

Department of Civil, Geological and Mining Engineering, Polytechnique Montréal, Montreal, QC H3C 3A7, Canada.

Elisabeth Mercier (E)

Department of Civil Engineering, University of Ottawa, Ottawa, ON K1N 6N5, Canada.

Stephanie Katharine Loeb (SK)

Department of Civil Engineering, McGill University, Montreal, QC H3A 0C3, Canada.

Peter A Vanrolleghem (PA)

modelEAU, Département de génie civil et de génie des eaux, Université Laval, Québec City, QC G1V 0A6, Canada.

Sarah Dorner (S)

Department of Civil, Geological and Mining Engineering, Polytechnique Montréal, Montreal, QC H3C 3A7, Canada.

Robert Delatolla (R)

Department of Civil Engineering, University of Ottawa, Ottawa, ON K1N 6N5, Canada.

B Jesse Shapiro (BJ)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.

Dominic Frigon (D)

Department of Civil Engineering, McGill University, Montreal, QC H3A 0C3, Canada.

Jiannis Ragoussis (J)

McGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.
Department of Bioengineering, McGill University, Montreal, QC H3A 0E9, Canada.

Terrance P Snutch (TP)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH